Abstract: A method of treating or preventing pruritus in a subject in need thereof using a pharmaceutical composition is provided. The method includes administering a therapeutically effective amount of T?4, T?4 fragments, T?4 isoforms, T?4 derivatives, or variants thereof, wherein the therapeutically effective amount decreases release of a pruritus-related factor or decreases release of an inflammatory cytokine from a target tissue is provided.
Type:
Application
Filed:
February 12, 2021
Publication date:
January 26, 2023
Applicant:
HLB THERAPEUTICS CO., LTD.
Inventors:
Sin Wook KANG, Ji Hye SUNG, Won Suk YANG